Intelligence / Healthtech / FDA 510(k) Clearances / Kossan International Sdn Bhd
Kossan International Sdn Bhd
18 Aug 2026: Device cleared · NON-STERILE POWDER FREE NITRILE PATIENT EXAMINATION GLOVES, WITH LICORICE ROOT EXTRACT AND UREA, TESTED FOR USE WITH CHEMOTHERAPY DRUGS, FENTANYL CITRATE, XYLAZINE HCl, AND GASTRIC ACID. OCEAN COLOR. Recorded in the openFDA device 510(k) data.
- Decided
- 18 Aug 2026
- Device
- NON-STERILE POWDER FREE NITRILE PATIENT EXAMINATION GLOVES, WITH LICORICE ROOT EXTRACT AND UREA, TESTED FOR USE WITH CHEMOTHERAPY DRUGS, FENTANYL CITRATE, XYLAZINE HCl, AND GASTRIC ACID. OCEAN COLOR
- Specialty
- General Hospital
- Country
- Malaysia
- Location
- Shah Alam
- Clearance type
- Traditional
- 510(k) number
- K260794
- Submitted
- 2026-03-11
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at Kossan International Sdn Bhd
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General Hospital
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.